-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NWK6BVLMvU8heJdQeaJXWapDPgFJuGdTCRE2RXVM+O2G5O0W5SHmVDBqORWfeSEe WKdBZlPgvLZV0ZdUF5jY0A== 0001209191-04-047404.txt : 20041005 0001209191-04-047404.hdr.sgml : 20041005 20041005142916 ACCESSION NUMBER: 0001209191-04-047404 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041001 FILED AS OF DATE: 20041005 DATE AS OF CHANGE: 20041005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GODDARD COLIN CENTRAL INDEX KEY: 0001225199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 041065518 BUSINESS ADDRESS: STREET 1: OSI PHARMACEUTICALS INC STREET 2: 58 S. SERVICE RD. CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-10-01 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001225199 GODDARD COLIN C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 1 1 0 0 Chief Executive Officer Common Stock 2004-10-01 4 M 0 8350 5.25 A 42549 D Common Stock 2004-10-01 4 S 0 156 60.75 D 42393 D Common Stock 2004-10-01 4 S 0 106 60.76 D 42287 D Common Stock 2004-10-01 4 S 0 75 60.77 D 42212 D Common Stock 2004-10-01 4 S 0 37 60.78 D 42175 D Common Stock 2004-10-01 4 S 0 187 60.80 D 41988 D Common Stock 2004-10-01 4 S 0 75 60.81 D 41913 D Common Stock 2004-10-01 4 S 0 38 60.83 D 41875 D Common Stock 2004-10-01 4 S 0 3739 60.96 D 38136 D Common Stock 2004-10-01 4 S 0 872 61.00 D 37264 D Common Stock 2004-10-01 4 S 0 112 61.05 D 37152 D Common Stock 2004-10-01 4 S 0 150 61.07 D 37002 D Common Stock 2004-10-01 4 S 0 112 61.09 D 36890 D Common Stock 2004-10-01 4 S 0 971 61.10 D 35919 D Common Stock 2004-10-01 4 S 0 37 61.11 D 35882 D Common Stock 2004-10-01 4 S 0 150 61.18 D 35732 D Common Stock 2004-10-01 4 S 0 37 61.19 D 35695 D Common Stock 2004-10-01 4 S 0 37 61.25 D 35658 D Common Stock 2004-10-01 4 S 0 150 61.30 D 35508 D Common Stock 2004-10-01 4 S 0 299 61.55 D 35209 D Common Stock 2004-10-01 4 S 0 598 61.60 D 34611 D Common Stock 2004-10-01 4 S 0 75 61.75 D 34536 D Common Stock 2004-10-01 4 S 0 337 61.83 D 34199 D Stock Option (Right to Buy) 5.25 2004-10-01 4 M 0 8350 0.00 D 1999-06-18 2008-06-17 Common Stock 8350 7650 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2004-10-05 -----END PRIVACY-ENHANCED MESSAGE-----